Safilo Group S.p.A., together with its subsidiaries, designs, manufactures, and distributes optical frames, sunglasses, sports eyewear, goggles, and helmets in North America, Europe, the Asia Pacific, and internationally. The company offers fashion items under the Boss, Carolina Herrera, Dsquared2, Etro, Isabel Marant, Missoni, Moschino, PORTS, and Victoria Beckham brand names; lifestyle products under the Carrera, Eyewear by David Beckham, Marc Jacobs, Levi's, Tommy Hilfiger, Tommy Jeans, Kate Spade New York, Kurt Geiger, Fossil, HUGO, Juicy Couture, Liz Claiborne, Love Moschino, Pierre Cardin, and Stuart Weitzman brand names; sports and outdoor items under the Smith and Under Armour brand names; and mass cool products under the Blenders, Polaroid, Privé Revaux, and Seventh Street brand names. It sells its products to opticians, optometrists, ophthalmologists, retail chains, department stores, specialty retailers, boutiques, duty free, and sports stores through a network of independent distribution partners, direct-to-consumer e-commerce platforms, and online sales channels. The company was formerly known as Società Azionaria Fabbrica Italiana Lavorazione Occhiali S.p.A. and changed its name to Safilo Group S.p.A. in June 2007. Safilo Group S.p.A. was founded in 1878 and is headquartered in Padua, Italy.…
Safilo svela i progetti per il mercato francese (e non solo)
Safilo Group (BIT: SFL) is listed on Borsa Italiana, where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 3,368 employees.
The shares were at 2.110 EUR on 20 November 2026, up 16.6% over 52 weeks. Its 52-week range is 1.497 EUR to 2.396 EUR: the price is 11.9% below the high and 40.9% above the low.
At a market capitalisation of 815.52M EUR, it trades at 17.6 times trailing earnings and 15.2 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, a discount of 64% for SFL.
Safilo Group reports return on equity of 12.4%, an operating margin of 7.2% and revenue down 4.8% year over year.
Its debt exceeds its cash by 5.40M EUR, a debt-to-equity ratio of 0.25. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 2.263 EUR is 7.3% above the current price. The next earnings report is expected on 11 March 2027.